Sharon D B de Morais1, Julia Shanks1, Irving H Zucker2. 1. Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, 68198-5850, USA. 2. Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, 68198-5850, USA. izucker@unmc.edu.
Abstract
PURPOSE OF REVIEW: The renin-angiotensin system (RAS) plays an important role in modulating cardiovascular function and fluid homeostasis. While the systemic actions of the RAS are widely accepted, the role of the RAS in the brain, its regulation of cardiovascular function, and sympathetic outflow remain controversial. In this report, we discuss the current understanding of central RAS on blood pressure (BP) regulation, in light of recent literature and new experimental techniques. RECENT FINDINGS: Studies using neuronal or glial-specifc mouse models have allowed for greater understanding into the site-specific expression and role centrally expressed RAS proteins have on BP regulation. While all components of the RAS have been identified in cardiovascular regulatory regions of the brain, their actions may be site specific. In a number of animal models of hypertension, reduction in Ang II-mediated signaling, or upregulation of the central ACE2/Ang 1-7 pathway, has been shown to reduce BP, via a reduction in sympathetic signaling and increase parasympathetic tone, respectively. Emerging evidence also suggests that, in part, the female protective phenotype against hypertension may be due to inceased ACE2 activity within cardiovascular regulatory regions of the brain, potentially mediated by estrogen. Increasing evidence suggests the importance of a central renin-angiotensin pathway, although its localization and the mechanisms involved in its expression and regulation still need to be clarified and more precisely defined. All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
PURPOSE OF REVIEW: The renin-angiotensin system (RAS) plays an important role in modulating cardiovascular function and fluid homeostasis. While the systemic actions of the RAS are widely accepted, the role of the RAS in the brain, its regulation of cardiovascular function, and sympathetic outflow remain controversial. In this report, we discuss the current understanding of central RAS on blood pressure (BP) regulation, in light of recent literature and new experimental techniques. RECENT FINDINGS: Studies using neuronal or glial-specifc mouse models have allowed for greater understanding into the site-specific expression and role centrally expressed RAS proteins have on BP regulation. While all components of the RAS have been identified in cardiovascular regulatory regions of the brain, their actions may be site specific. In a number of animal models of hypertension, reduction in Ang II-mediated signaling, or upregulation of the central ACE2/Ang 1-7 pathway, has been shown to reduce BP, via a reduction in sympathetic signaling and increase parasympathetic tone, respectively. Emerging evidence also suggests that, in part, the female protective phenotype against hypertension may be due to inceased ACE2 activity within cardiovascular regulatory regions of the brain, potentially mediated by estrogen. Increasing evidence suggests the importance of a central renin-angiotensin pathway, although its localization and the mechanisms involved in its expression and regulation still need to be clarified and more precisely defined. All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Entities:
Keywords:
Angiotensin; Blood pressure; Brain; Hypertension; Renin; Sympathetic nervous system
Authors: S Nakamura; A Moriguchi; R Morishita; K Yamada; T Nishii; N Tomita; M Ohishi; Y Kaneda; J Higaki; T Ogihara Journal: Hypertension Date: 1999-08 Impact factor: 10.190
Authors: M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205
Authors: Keisuke Shinohara; Pablo Nakagawa; Javier Gomez; Donald A Morgan; Nicole K Littlejohn; Matthew D Folchert; Benjamin J Weidemann; Xuebo Liu; Susan A Walsh; Laura L Ponto; Kamal Rahmouni; Justin L Grobe; Curt D Sigmund Journal: Hypertension Date: 2017-09-05 Impact factor: 10.190
Authors: María J Guil; Mercedes I Schöller; Luis R Cassinotti; Vinicia C Biancardi; Soledad Pitra; Liliana G Bianciotti; Javier E Stern; Marcelo S Vatta Journal: Biochim Biophys Acta Mol Basis Dis Date: 2019-08-06 Impact factor: 5.187
Authors: Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott Journal: Hypertension Date: 2018-09 Impact factor: 10.190
Authors: George E Farmer; Anna Amune; Martha E Bachelor; Phong Duong; Joseph P Yuan; J Thomas Cunningham Journal: Sci Rep Date: 2019-06-19 Impact factor: 4.379